Is early CLL treatment worth the cost? new study aims to find out

NCT ID NCT05371808

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study looks at the costs and quality of life for people with high-risk chronic lymphocytic leukemia (CLL) who either start treatment right away or wait. Researchers will track medical visits, tests, and hospital stays over 10 years. The goal is to see which approach gives the best value for the healthcare system.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors and health systems decide the most cost-effective timing for treating high-risk CLL, potentially saving money while maintaining patient outcomes.
What could go wrong
This is an economic analysis, not a treatment trial, so it won't directly improve health. Results depend on assumptions and may not apply outside Canada.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BCCA - Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

  • CancerCare Manitoba

    RECRUITING

    Winnipeg, Manitoba, R3E 0V9, Canada

  • Lakeridge Health Oshawa

    NOT_YET_RECRUITING

    Oshawa, Ontario, L1G 2B9, Canada

  • Ottawa Hospital Research Institute

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • Regional Health Authority B, Zone 2

    RECRUITING

    Saint John, New Brunswick, E2L 4L2, Canada

  • The Jewish General Hospital

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.